Phreesia, Inc. (PHR)
NYSE · Healthcare · Health Information Services
$10.37+2.98%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $644M
- P/E (trailing)
- 61.0
- Forward P/E
- 6.6
- 52-week range
- $7.77 – $24.25
- 52-week change
- −57.11%
- EPS (trailing)
- $0.17
- Analyst rating
- 2.0 Buy
Fiscal year to Jan 2026
- Revenue
- $481M (+14.48%)
- Net income
- $2.3M
- Operating margin
- −1.4%
- Diluted EPS
- $0.04
- Free cash flow
- $67.7M
From the company’s annual report on SEC EDGAR.
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Headquarters: Wilmington, United States · 1,789 employees · phreesia.com